Dip-buying absent in early NY trading, Wall Street deep in red as trade war fears escalate despite strong jobs report. Investors on edge for hints from Fed Chair Powell.
As President Trump heads off to play golf, China remains at work, swiftly retaliating against US Exports with a 34% tariff in response to Trump’s 54% tariff on $ 450B in Chinese goods.
IonQ CEO said the company sells quantum computing systems worldwide and that its next-generation system will be about 240 million times more powerful than its predecessor.
Munster said tariffs don’t change the reality that the race to general intelligence is the most significant tech, economic and geopolitical shift in 25 years.
In this video, I break down the technical analysis behind today’s sell-off, covering key support and resistance levels, and discuss what traders need to watch next.
One thing is clear from yesterday’s “Liberation Day” tariff announcement –the market has decided that there is pretty much no way to spin it as a positive.
Aldeyra Therapeutics CEO Todd C Brady said the company looks forward to a potential application resubmission by mid-year 2025, pending positive results from ongoing clinical trials and discussions with the FDA.
The iShares Russell 2000 ETF which tracks small-cap stocks, plunged 5% on Thursday. President Donald Trump's sweeping reciprocal tariffs roiled financial markets and heightened concerns about an economic downturn.
President Donald Trump's sweeping new trade tariffs sent shockwaves through global markets on Thursday, triggering a massive sell-off that echoed the COVID-19 pandemic-era routs, as investor risk appetite vanished in a flash.
Asian markets closed mostly lower on Thursday, led by Japan’s Nikkei 225 Index, which plunged 2.77% before settling at an eight-month low, while European stocks started sharply lower.
The research firm surmised that the design contract Vishay Precision Group secured in late 2023 with an unnamed, leading humanoid robot developer is none other than Tesla's Optimus.
Though the FDA was set to give full approval to the vaccine, senior leaders at the agency have now said that the company’s application needs more data and is unlikely to be approved soon, The Wall Street Journal reported.
Wall Street extends gains on Wednesday, as investors remain resilient in their risk appetite despite the looming announcement of sweeping trade tariffs by President Donald Trump.
The medical technology company now expects net sales to be $285 to $288 million for the fiscal year 2025, up from previously issued guidance of $282 to $288 million, owing to increased medical technology net sales.
